Van Strydonck, Gerald E. 4/A
4/A · VACCINEX, INC. · Filed Jan 6, 2020
Insider Transaction Report
Form 4/AAmended
VACCINEX, INC.VCNX
Van Strydonck, Gerald E.
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-09-30+1,856→ 1,856 totalExercise: $7.17From: 2019-09-30Exp: 2029-09-27→ Common Stock (1,856 underlying)
Footnotes (2)
- [F1]The original Form 4 contained an incorrect expiration date for these options. This amendment is being filed to correct the expiration date.
- [F2]Pursuant to the Issuer's Director Compensation Program, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2019. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.